For the 2nd year in a row, cancer death rates in the US have fallen. Researchers cite changes in behavior (smoking, etc.) as the main driver for the improvement
These figures are for 2004, so much of the progress in targeted therapies is not yet reflected in the statistics. However, the biggest %age drop in death rates occurred in colorectal cancer, which could be influenced by the use of Erbitux and Avastin - both approved in 2004.
One stunning nugget from the ACS stats: males have a 45.3% chance of developing a cancer during their lifetime. (Women: 37.8%)
Wednesday, January 17, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment